Image pharmaphorum Editor Healthcare How medical device sales teams can embrace digital transform... Selling amid a global pandemic has changed the face of sales forever. M&A How to get acquisition ready – a seller’s guide to merger an... This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we near the end of the year, there were some big moves. Digital Curavit’s crystal ball – how will 2023 drive meaningful chan... The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways. Sustainability Life sciences faces a battle with sustainability, but let’s ... We know that the global healthcare sector is a contributor to the warming of our planet. Load more results
Healthcare How medical device sales teams can embrace digital transform... Selling amid a global pandemic has changed the face of sales forever.
M&A How to get acquisition ready – a seller’s guide to merger an... This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we near the end of the year, there were some big moves.
Digital Curavit’s crystal ball – how will 2023 drive meaningful chan... The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways.
Sustainability Life sciences faces a battle with sustainability, but let’s ... We know that the global healthcare sector is a contributor to the warming of our planet.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.